Suppr超能文献

经支气管活检术在肺动脉高压患者中的安全性:系统评价和荟萃分析。

Safety of Transbronchial Biopsies in Patients with Pulmonary Hypertension: Systematic Review and Meta-Analysis.

机构信息

Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, New York.

Mountainstar Healthcare, Salt Lake City, Utah.

出版信息

Ann Am Thorac Soc. 2023 Jun;20(6):898-905. doi: 10.1513/AnnalsATS.202211-965OC.

Abstract

Transbronchial lung biopsies (TBLBs) are commonly performed by pulmonologists. Most providers consider pulmonary hypertension to be at least a relative contraindication to TBLB. This practice is based primarily on expert opinion, as there are very few patient outcomes data backing it. We performed a systematic review and meta-analysis of previously published studies to determine the safety of TBLB in patients with pulmonary hypertension. The MEDLINE, Embase, Scopus, and Google Scholar databases were searched for pertinent studies. The quality of the included studies was assessed using the Newcastle-Ottawa Scale. Meta-analysis was performed using MedCalc version 20.118 to calculate the weighted pooled relative risk of complications in patients with pulmonary hypertension. Nine studies with a total of 1,699 patients were included in the meta-analysis. On the basis of the Newcastle-Ottawa Scale, the risk of bias was low in the included studies. The overall weighted relative risk of bleeding with TBLB in patients with pulmonary hypertension was 1.01 (95% confidence interval, 0.71-1.45) compared with patients without pulmonary hypertension. Heterogeneity was low; therefore, the fixed-effects model was used. In a subgroup analysis of three studies, the overall weighted relative risk of significant hypoxia in patients with pulmonary hypertension was 2.06 (95% confidence interval, 1.12-3.76). Our results show that the patients with pulmonary hypertension do not have a significantly elevated risk of bleeding with TBLB compared with control subjects. We hypothesize that significant postbiopsy bleeding might be preferentially originating from bronchial artery circulation as opposed to pulmonary artery circulation, much like episodes of massive spontaneous hemoptysis. This hypothesis can explain our results, as in this scenario, elevated pulmonary arterial pressure would not be expected to have a bearing on the risk of post-TBLB bleeding. Most of the studies in our analysis included patients with mild to moderate pulmonary hypertension and it is not clear if our results can be extrapolated to patients with severe pulmonary hypertension. We noted that the patients with pulmonary hypertension were at a higher risk of developing hypoxia and needing a longer duration of mechanical ventilation with TBLB compared with control subjects. Further studies are needed to better understand the origin and pathophysiology of post-TBLB bleeding.

摘要

经支气管肺活检(TBLB)通常由肺科医生进行。大多数医生认为肺动脉高压至少是 TBLB 的相对禁忌证。这种做法主要基于专家意见,因为很少有患者结局数据支持这一点。我们对之前发表的研究进行了系统评价和荟萃分析,以确定 TBLB 在肺动脉高压患者中的安全性。我们在 MEDLINE、Embase、Scopus 和 Google Scholar 数据库中搜索了相关研究。使用纽卡斯尔-渥太华量表评估纳入研究的质量。使用 MedCalc 版本 20.118 进行荟萃分析,以计算肺动脉高压患者并发症的加权汇总相对风险。纳入了 9 项共 1699 名患者的研究。基于纽卡斯尔-渥太华量表,纳入研究的偏倚风险较低。与无肺动脉高压患者相比,肺动脉高压患者 TBLB 后出血的总体加权相对风险为 1.01(95%置信区间,0.71-1.45)。异质性较低;因此,使用固定效应模型。在对三项研究的亚组分析中,肺动脉高压患者发生显著低氧血症的总体加权相对风险为 2.06(95%置信区间,1.12-3.76)。我们的结果表明,与对照组相比,肺动脉高压患者 TBLB 后出血的风险没有显著升高。我们假设,明显的活检后出血可能更倾向于源自支气管动脉循环,而不是肺动脉循环,就像大咯血发作一样。这个假设可以解释我们的结果,因为在这种情况下,升高的肺动脉压预计不会影响 TBLB 后出血的风险。我们分析中的大多数研究都纳入了轻度至中度肺动脉高压患者,目前尚不清楚我们的结果是否可以外推至重度肺动脉高压患者。我们注意到,与对照组相比,肺动脉高压患者 TBLB 后发生低氧血症和需要更长时间机械通气的风险更高。需要进一步的研究来更好地了解 TBLB 后出血的起源和病理生理学。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验